Human Insulin Market Share, Size, & Growth

Global Human Insulin Market Research Report: Forecast (2023-2028)

By Product Type (Human Insulin Drugs [Insulin Analogs & Biosimilars, Human Insulin Biologics], Human Insulin Delivery Devices [Syringes, Pens, Pen Needles]), By Application (Type I...... Diabetes, Type II Diabetes), By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific), By Company (B. Braun (B. Braun Melsungen), Becton, Dickinson and Company (BD), Biocon Limited, Biodel Inc., Eli Lilly and Company, Julphar (Gulf Pharmaceutical Industry), Novo Nordisk A/S, Sanofi, Wockhardt Ltd., The Ypsomed Group, Others) Read more

Healthcare
Mar 2023
Pages 197
Report Format: PDF, Excel, PPT

Market Definition

Insulin is a pharmaceutical preparation of the protein hormone insulin produced by the human pancreas. It controls the amount of glucose (sugar) levels in the bloodstream, regulates the uptake of amino acids by body cells, and the metabolism of fats, proteins, and carbohydrates. Diabetes is a chronic medical condition in which the human body does not produce enough insulin or the cells stop responding to the it, leading to too much blood sugar in the bloodstream. This condition can cause health problems such as heart disease, vision loss, etc., and requires the administration of such harmone on a daily basis.

Market Insights & Analysis: Global Human Insulin Market (2023-28)

The Global Human Insulin Market is projected to grow at a CAGR of around 5.4% during the forecast period, i.e., 2023-28. The increasing number of diabetes cases globally favors market growth. In addition, the growing exposure of people to risk factors such as a sedentary lifestyle and obesity is increasing the chances of diseases and conditions like diabetes and high blood pressure. Thus, the rising prevalence of diabetes supports the adoption of human insulin as a treatment, fueling market expansion.

Technological advancements, research, and development in product variations and delivery methods have played a significant role in accelerating market growth. For instance, Afrezza (Mannkind) is the only inhaled form available, eliminating the need for needles and syringes. Fiasp (Novo Nordisk) is a formulation combined with Vitamin B3 (niacinamide) to improve initial absorption.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
CAGR (2023-2028)	5.4%
Regions Covered	North America: US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
	South America: Brazil, Argentina, Rest of South America
	Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled	B. Braun (B. Braun Melsungen), Becton, Dickinson and Company (BD), Biocon Limited, Biodel Inc., Eli Lilly and Company, Julphar (Gulf Pharmaceutical Industry), Novo Nordisk A/S, Sanofi, Wockhardt Ltd., The Ypsomed Group, Others
Unit Denominations	USD Million/Billion

Favorable reimbursement policies in developed countries support the adoption of human insulin. However, the lack of such policies in emerging nations and undiagnosed cases could hinder market expansion. Meanwhile, the shift of consumers to analogs and biosimilars from human insulin biologics is likely to garner the attention of the growing diabetes population, promising further industrial opportunities. For instance,

In July 2021, Semglee, an insulin product interchangeable with and biosimilar to Lantus made by India’s Biocon, got United States approval.

Global Human Insulin Market Research Report (2023-2028) - Table of Contents

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Human Insulin Market Porters Five Forces Analysis
Global Human Insulin Market Trends & Insights
Global Human Insulin Market Dynamics
1. Drivers
2. Challenges
Global Human Insulin Market Growth Opportunities & Hotspots
Global Human Insulin Market Policy & Regulations
Global Human Insulin Market Analysis, 2018-2028F
1. Market Size & Outlook
  1. Revenues (USD Million)
2. Market Share & Outlook
  1. By Product Type
    1. Human Insulin Drugs
      1. Insulin Analogs & Biosimilars
        
        Long Acting Biosimilars
        
        Rapid Acting Biosimilars
        
        Premixed Biosimilars
      2. Human Insulin Biologics
        
        Short Acting Biologics
        
        Intermediate Acting Biologics
        
        Premixed Biologics
    2. Human Insulin Delivery Devices
      1. Syringes
      2. Pens
        
        Disposable Pens
        
        Reusable Pens
      3. Pen Needles
        
        Standard Pen Needles
        
        Safety Pen Needles
  2. By Application
    1. Type I Diabetes
    2. Type II Diabetes
  3. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  4. By Company
    1. Market Share
    2. Competition Characteristics
North America Human Insulin Market Analysis, 2018-2028F
1. Market Size & Outlook
  1. Revenues (USD Million)
2. Market Share & Outlook
  1. By Product Type
  2. By Application
  3. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
4. Canada Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
5. Mexico Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
South America Human Insulin Market Analysis, 2018-2028F
1. Market Size & Outlook
  1. Revenues (USD Million)
2. Market Share & Outlook
  1. By Product Type
  2. By Application
  3. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
4. Argentina Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
Europe Human Insulin Market Analysis, 2018-2028F
1. Market Size & Outlook
  1. Revenues (USD Million)
2. Market Share & Outlook
  1. By Product Type
  2. By Application
  3. By Country
    1. The UK
    2. Germany
    3. Italy
    4. France
    5. Spain
    6. Rest of Europe
3. The UK Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
4. Germany Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
5. Italy Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
6. France Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
7. Spain Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
The Middle East & Africa Human Insulin Market Analysis, 2018-2028F
1. Market Size & Outlook
  1. Revenues (USD Million)
2. Market Share & Outlook
  1. By Product Type
  2. By Application
  3. By Country
    1. GCC
    2. South Africa
    3. Rest of the Middle East & Africa
3. GCC Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
4. South Africa Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
Asia-Pacific Human Insulin Market Analysis, 2018-2028F
1. Market Size & Outlook
  1. Revenues (USD Million)
2. Market Share & Outlook
  1. By Product Type
  2. By Application
  3. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. Rest of Asia-Pacific
3. China Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
4. India Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
5. Japan Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
6. South Korea Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
7. Australia Human Insulin Market Analysis, 2018-2028F
  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Product Type
    2. By Application
Global Human Insulin Market Key Strategic Imperatives for Success & Growth
Competitive Benchmarking
1. Competition Matrix
  1. Product Portfolio
  2. Target Markets
  3. Target End Users
  4. Research & Development
  5. Strategic Alliances
  6. Strategic Initiatives
2. Company Profiles (Business Description, Product Offering, Strategic Alliances or Partnerships, etc)
  1. B. Braun (B. Braun Melsungen)
  2. Becton, Dickinson and Company (BD)
  3. Biocon Limited
  4. Biodel Inc.
  5. Eli Lilly and Company
  6. Julphar (Gulf Pharmaceutical Industry)
  7. Novo Nordisk A/S
  8. Sanofi
  9. Wockhardt Ltd.
  10. The Ypsomed Group
  11. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying